Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe

Area of Science:

• Infectious Diseases
• Public Health
• Epidemiology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant global pathogen.
• MRSA infections cause substantial morbidity, mortality, and economic burden in European healthcare systems.
• Surveillance data reveal wide variations in MRSA prevalence across EU Member States.

Purpose of the Study:

• To review the current burden of MRSA infections in European healthcare and community settings.
• To outline emerging threats from recent epidemiological changes in MRSA.
• To identify unmet needs in MRSA surveillance, prevention, and control across Europe.

Main Methods:

• Review of pan-European surveillance data on bloodstream infections.
• Analysis of trends in MRSA bacteraemia rates over the past five years.
• Assessment of the emergence of community and livestock-associated MRSA strains.

Main Results:

• MRSA infections affect over 150,000 patients annually in the EU, costing EUR 380 million.
• MRSA bacteraemia rates have decreased in 10 EU countries with previously high endemic rates.
• New MRSA strains are emerging as pathogens in community and livestock settings.

Conclusions:

• MRSA remains a major public health concern in the EU.
• Recent epidemiological shifts necessitate updated strategies for MRSA prevention and control.
• Enhanced surveillance and targeted interventions are crucial to address evolving MRSA threats.